Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07511842

REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes

Led by Université de Sherbrooke · Updated on 2026-04-06

106

Participants Needed

1

Research Sites

147 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Postoperative pain following total knee arthroplasty (TKA) is often difficult to manage, particularly with the increasing use of outpatient surgery where patients recover at home. This study aims to evaluate whether wearing a knee extension brace for the first 72 hours after surgery can reduce pain and improve recovery. This pilot randomized controlled trial will compare two groups of patients undergoing primary unilateral TKA: one group will wear an extension brace continuously for 72 hours after surgery, while the control group will follow standard care with early mobilization. Participants will be followed for up to 12 months. The primary objective of this pilot study is to assess the feasibility of conducting a larger trial, including recruitment rates, adherence to the intervention, follow-up completion, safety, and acceptability. Clinical outcomes will also be explored, including pain at 2 and 6 weeks after surgery (measured using a visual analog scale), knee function, range of motion, opioid consumption, complications, healthcare use, and quality of life. The study hypothesizes that short-term immobilization of the knee in full extension will reduce postoperative pain and may improve early recovery outcomes. Findings from this pilot study will inform the design of a larger definitive trial and may contribute to improving postoperative care and pain management after knee replacement surgery.

CONDITIONS

Official Title

REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults undergoing primary unilateral total knee arthroplasty for knee osteoarthritis at CHUS
Not Eligible

You will not qualify if you...

  • Known thrombophilia or bleeding disorders
  • History of thromboembolic events
  • Contraindications to brace use such as material allergy
  • Revision or constrained knee prostheses
  • Use of continuous postoperative nerve block infusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CIUSSS de l'Estrie-CHUS, 3001, 12e Ave Nord, Sherbrooke, Qc, Canada, J1H 5N4

Sherbrooke, Quebec, Canada, J1K 2P2

Actively Recruiting

Loading map...

Research Team

S

Sonia Bedard, Masters

CONTACT

Y

Yoan Bourgeault-Gagnon, MD FRCSC

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here